Anavex Life Sciences (AVXL) Total Non-Current Liabilities (2012 - 2014)

Anavex Life Sciences (AVXL) posted Total Non-Current Liabilities of $1.9 million for Q2 2014, up 1.11% sequentially from $1.9 million in Q1 2014.

Anavex Life Sciences (AVXL) Total Non-Current Liabilities (2012 - 2014) Analysis & Trends

Anavex Life Sciences has reported Total Non-Current Liabilities for 3 years, with the latest figure at $1.9 million in Q2 2014.

Quarterly Total Non-Current Liabilities changed N/A year-over-year to $1.9 million in Q2 2014, while the trailing twelve-month figure through Jun 2014 was $1.9 million (changed N/A YoY) and the FY2013 annual result came in at $2.0 million, down 32.39% from the prior year.
Total Non-Current Liabilities advanced to $1.9 million in Q2 2014 per AVXL's latest filing, from $1.9 million in the prior quarter.
Over five years, Total Non-Current Liabilities peaked at $2.9 million in Q3 2012 and troughed at $1.8 million in Q4 2013.
A 3-year average of $2.1 million and a median of $1.9 million in 2014 frame the typical range for Total Non-Current Liabilities.
The widest YoY moves for Total Non-Current Liabilities: up 32.39% in 2013, down 32.39% in 2013.
Over 3 years, Total Non-Current Liabilities stood at $2.9 million in 2012, then plunged by 36.95% to $1.8 million in 2013, then advanced by 4.62% to $1.9 million in 2014.
According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.9 million, $1.9 million, and $1.8 million for Q2 2014, Q1 2014, and Q4 2013 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Non-Current Liabilities (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	5.92 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	7.74 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	40.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	1.53 Bn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	1.88 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	9.32 Bn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	4.20 Bn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	1.17 Bn
10	Anavex Life Sciences	298.40 Mn	166.65 Mn	-	-

Download Data